Patents by Inventor Jerry Min-Jian Huang

Jerry Min-Jian Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110190312
    Abstract: The invention relates to a combination which comprises: (a) an epothilone; and (b) a protein tyrosine kinase inhibitor; and optionally (c) a derivative of rapamycin; for simultaneous, separate or sequential use, in particular, for the delay of progression or treatment of a proliferative disease, especially cancer.
    Type: Application
    Filed: April 13, 2011
    Publication date: August 4, 2011
    Inventors: Jerry Min-Jian Huang, Anandhi Ranganathan Johri, Ronald Richard Linnartz, Paul M.J. McSheehy
  • Publication number: 20080139587
    Abstract: The invention relates to a combination which comprises: (a) an epothilone; and (b) a protein tyrosine kinase inhibitor; and optionally (c) a derivative of rapamycin; for simultaneous, separate or sequential use, in particular, for the delay of progression or treatment of a proliferative disease, especially cancer.
    Type: Application
    Filed: November 28, 2005
    Publication date: June 12, 2008
    Applicant: Novartis Ag
    Inventors: Jerry Min-Jian Huang, Anandhi Ranganathan Johri, Ronald Richard Linnartz, Paul M.J. McSheehy
  • Publication number: 20080085902
    Abstract: The present invention relates to a combination therapy for treating patients suffering from proliferative diseases or diseases associated with persistent angiogenesis. The patient is treated with a VEGF inhibitor compound; and one or more chemotherapeutic agents.
    Type: Application
    Filed: September 23, 2004
    Publication date: April 10, 2008
    Inventors: Guido Bold, Josef Bernhard Brueggen, Jerry Min-Jian Huang, Frederick Ray Kinder, Heidi Lane, Elisabeth Jeanne Latour, Paul W. Manley, Jeanette Marjorie Wood